Common Stock Compensation

9 Months Ended

Mar. 31, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

(11) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the nine months ended March 31, 2018, is as follows:

	Shares (in thousands)		Weighted Average Exercise Price
Outstanding at June 30, 2017		365	$	6.07
Granted		—		—
Exercised		—		—
Canceled or expired		3		5.30
Outstanding at March 31, 2018		362	$	5.48

The aggregate intrinsic value of options exercisable at March 31, 2018, was $14 thousand as the fair value of the Company’s common stock is more than the exercise prices of these options. The remaining share-based compensation expense of $421 thousand related to stock options will be recognized over a weighted-average period of 2.09 years.

The table below details the Company’s stock options outstanding as of March 31, 2018:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$1.60 – 3.55		93,950		3.38	$	3.06		89,217	$	3.07
$5.30 – 8.35		267,621		7.92		6.30		86,000		6.59
$16.00 – 16.00		600		7.02		16.00		600		16.00
$1.60 – 16.00		362,171		6.74	$	5.48		175,817	$	4.84

Compensation costs recognized related to stock option awards were $93 thousand and $17 thousand for the three months ended March 31, 2018, and 2017, respectively and $226 thousand and $50 thousand for the nine months ended March 31, 2018 and 2017, respectively.

Restricted Stock

The Company’s restricted stock activity for the nine months ended March 31, 2018, is as follows:

	Shares (in thousands)		Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2017		56	$	9.95
Granted		—		—
Vested		6		9.22
Canceled or expired		3		8.35
Outstanding at March 31, 2018		47	$	10.16

Stock compensation expenses related to restricted stock were $53 thousand and $71 thousand for the three months ended March 31, 2018, and 2017, respectively and $161 thousand and $207 thousand for the nine months ended March 31, 2018 and 2017, respectively. The remaining share-based compensation expense of $86 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 1.23 years.